Page last updated: 2024-08-26

melanotan-ii and Atherosclerosis

melanotan-ii has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hellberg, S; Knuuti, J; Koskinen, E; Liljenbäck, H; Nuutinen, S; Rinne, P; Roivainen, A; Salomäki, H; Saraste, A; Saukko, P; Savontaus, E; Silvola, JM; Ståhle, M	1

Other Studies

1 other study(ies) available for melanotan-ii and Atherosclerosis

Article	Year
Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7 Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins B; Atherosclerosis; Biomarkers; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Inflammation; Inflammation Mediators; Lipids; Macrophages; Male; Mice; Mice, Knockout; Peptides, Cyclic; Phenotype; Plaque, Atherosclerotic; Radionuclide Imaging; Receptors, LDL; Receptors, Melanocortin; Signal Transduction; Vasodilation; Vasodilator Agents	2014

Article

Year

Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.

Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins B; Atherosclerosis; Biomarkers; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Inflammation; Inflammation Mediators; Lipids; Macrophages; Male; Mice; Mice, Knockout; Peptides, Cyclic; Phenotype; Plaque, Atherosclerotic; Radionuclide Imaging; Receptors, LDL; Receptors, Melanocortin; Signal Transduction; Vasodilation; Vasodilator Agents

2014